Assignee
CELLECTIS
FR80 patents
Top patents by PatentIndex Score
US9855297B2Jan 2, 2018
Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system
CELLECTIS50 citations97
US7842489B2Nov 30, 2010
Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
CELLECTIS63 citations95
US9944702B2Apr 17, 2018
CD33 specific chimeric antigen receptors for cancer immunotherapy
CELLECTIS29 citations94
US9944709B2Apr 17, 2018
CD123 specific chimeric antigen receptors for cancer immunotherapy
CELLECTIS21 citations94
US9890393B2Feb 13, 2018
Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system
CELLECTIS38 citations94
US10584352B2Mar 10, 2020
Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
CELLECTIS21 citations93
US10874693B2Dec 29, 2020
CD19 specific chimeric antigen receptor and uses thereof
CELLECTIS7 citations92
US10426795B2Oct 1, 2019
Use of preTalpha or functional variant thereof for expanding TCRalpha deficient T cells
CELLECTIS8 citations92
US10286007B2May 14, 2019
Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells
CELLECTIS12 citations92
US7897372B2Mar 1, 2011
I-CreI meganuclease variants with modified specificity, method of preparation and uses thereof
CELLECTIS42 citations91
US10836998B2Nov 17, 2020
Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells
CELLECTIS5 citations84
US10378026B2Aug 13, 2019
RNA based method to obtain stably integrated retroviral vectors
CELLECTIS6 citations84
US10316101B2Jun 11, 2019
BCMA (CD269) specific chimeric antigen receptors for cancer immunotherapy
CELLECTIS11 citations84
US10239948B2Mar 26, 2019
Method of engineering multi-input signal sensitive T cell for immunotherapy
CELLECTIS16 citations84
US10196608B2Feb 5, 2019
Method for in situ inhibition of regulatory T cells
CELLECTIS8 citations84
US10006052B2Jun 26, 2018
Laglidadg homing endonuclease cleaving the C-C chemokine receptor type-5 (CCR5) gene and uses thereof
CELLECTIS17 citations84
US11274316B2Mar 15, 2022
Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells
CELLECTIS2 citations83
US11077144B2Aug 3, 2021
CD19 specific chimeric antigen receptor and uses thereof
CELLECTIS7 citations83
US10870864B2Dec 22, 2020
Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
CELLECTIS4 citations83
US10752684B2Aug 25, 2020
ROR1 (NTRKR1) specific chimeric antigen receptors for cancer immunotherapy
CELLECTIS12 citations83
US10517896B2Dec 31, 2019
Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells
CELLECTIS2 citations83
US10363270B2Jul 30, 2019
Methods for engineering allogeneic and immunosuppressive resistant T cell immunotherapy
CELLECTIS6 citations83
US10759868B2Sep 1, 2020
Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen receptors for cancer immunotherapy
CELLECTIS6 citations82
US10342829B2Jul 9, 2019
Multi-chain chimeric antigen receptor and uses thereof
CELLECTIS6 citations81
US8003595B2Aug 23, 2011
Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
CELLECTIS7 citations78
US11014989B2May 25, 2021
Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs) for cancer immunotherapy
CELLECTIS2 citations73
US10988541B2Apr 27, 2021
CD123 specific chimeric antigen receptors for cancer immunotherapy
CELLECTIS1 citations73
US10709775B2Jul 14, 2020
Cells for immunotherapy engineered for targeting CD38 antigen and for CD38 gene inactivation
CELLECTIS7 citations73
US10472613B2Nov 12, 2019
Method for modulating car-induced immune cells activity
CELLECTIS6 citations73
US12577581B2Mar 17, 2026
Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells
CELLECTIS0 citations72
US11891614B2Feb 6, 2024
Methods for engineering allogeneic and immunosuppressive resistant T cell for immunotherapy
CELLECTIS1 citations72
US11466291B2Oct 11, 2022
Sequential gene editing in primary immune cells
CELLECTIS4 citations72
US11414674B2Aug 16, 2022
Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells
CELLECTIS0 citations72
US11304975B2Apr 19, 2022
Methods for engineering allogeneic and highly active t cell for immunotherapy
CELLECTIS4 citations72
US11186824B2Nov 30, 2021
Methods for engineering allogeneic T cell to increase their persistence and/or engraftment into patients
CELLECTIS4 citations72
US10113162B2Oct 30, 2018
Modifying soybean oil composition through targeted knockout of the FAD2-1A/1B genes
CELLECTIS6 citations69
US9365864B2Jun 14, 2016
Meganuclease recombination system
CELLECTIS3 citations69
US10087453B2Oct 2, 2018
Modified diatoms for biofuel production
CELLECTIS4 citations68
US11959091B2Apr 16, 2024
Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
CELLECTIS0 citations62
US11919961B2Mar 5, 2024
CD123 specific chimeric antigen receptors for cancer immunotherapy
CELLECTIS0 citations62
US11692169B2Jul 4, 2023
Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells
CELLECTIS0 citations62
US11498971B2Nov 15, 2022
BCMA (CD269) specific chimeric antigen receptors for cancer immunotherapy
CELLECTIS1 citations62
US11365430B2Jun 21, 2022
Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
CELLECTIS0 citations62
US11311575B2Apr 26, 2022
Methods for engineering highly active T cell for immunotherapy
CELLECTIS1 citations62
US11220683B2Jan 11, 2022
Method to overcome DNA chemical modifications sensitivity of engineered TALE DNA binding domains
CELLECTIS0 citations62
US11007224B2May 18, 2021
CD19 specific chimeric antigen receptor and uses thereof
CELLECTIS0 citations62
US10988542B2Apr 27, 2021
Chimeric antigen receptors with integrated controllable functions
CELLECTIS0 citations62
US10526406B2Jan 7, 2020
Chimeric antigen receptor using antigen recognition domains derived from cartilaginous fish
CELLECTIS1 citations62
US12391933B2Aug 19, 2025
Targeted gene insertion for improved immune cells therapy
CELLECTIS0 citations61
US12252699B2Mar 18, 2025
Method for generating t-cells compatible for allogenic transplantation
CELLECTIS0 citations61
Showing the top 50 of 80 patents by PatentIndex Score.